Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Diabetic Macular Edema (DME) Industry Expected To Reach By 2029, Starting From 2025 Levels?
The diabetic macular edema (dme) market size has shown consistent expansion in recent years. It is anticipated to increase from $4.67 billion in 2024 to $4.88 billion in 2025, at a compound annual growth rate (CAGR) of 4.4%. This historical growth can be linked to factors such as the increasing prevalence of diabetes, a rise in edema-related conditions, a greater incidence of diabetic eye diseases, an expanding geriatric population, and a higher number of blindness cases.
The diabetic macular edema (dme) market size is projected to show sustained expansion in the coming years, reaching $5.77 billion by 2029, with a compound annual growth rate (CAGR) of 4.3%. This anticipated growth is influenced by factors such as improved access to healthcare, an increase in government healthcare funding, heightened awareness regarding diabetic complications, the rising application of telemedicine for eye care, and the proliferation of specialized diabetic eye care centers. Significant trends in the forecast period encompass the evolution of anti-VEGF therapies, the incorporation of corticosteroid implants, advancements in drug delivery systems, innovations in retinal laser treatments, the emergence of AI-powered diagnostic tools, and the adoption of minimally invasive surgical techniques.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21169&type=smp
Which Drivers Are Impacting The Diabetic Macular Edema (DME) Market?
The increasing occurrence of diabetes is anticipated to propel the expansion of the diabetic macular edema (DME) market moving forward. This rising prevalence of diabetes is linked to elements such as inactive lifestyles, unhealthy eating habits, increasing obesity rates, an aging populace, and genetic susceptibility. Diabetes contributes to diabetic macular edema by causing damage to retinal blood vessels, which leads to fluid seeping into the macula and subsequently results in swelling. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, indicated that over half a billion people globally were affected by diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Hence, the growing prevalence of diabetes is stimulating the growth of the diabetic macular edema (DME) market.
What Are The Leading Segments Analyzed In The Diabetic Macular Edema (DME) Market?
The diabetic macular edema (dme)market covered in this report is segmented –
1) By Treatment: Anti-VEGF Therapy; Corticosteroids; Laser Therapy; Surgical Intervention
2) By Disease Stage: Early Stage; Moderate Stage; Advanced Stage
3) By Patient Demographics: Adults; Elderly; Children
4) By Route Of Administration: Intravitreal Injection; Topical; Systemic
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Anti-VEGF Therapy: Monoclonal Antibodies; Recombinant Protein-Based Therapies
2) By Corticosteroids: Intravitreal Steroid Injections; Injectable Sustained-Release Corticosteroids
3) By Laser Therapy: Focal Laser Photocoagulation; Panretinal Photocoagulation
4) By Surgical Intervention: Vitrectomy; Membrane Peeling
What Trends Are Expected To Drive The Diabetic Macular Edema (DME) Market?
Leading companies active in the diabetic macular edema (DME) treatment market are concentrating on technological breakthroughs, such as advanced drug therapies, to enhance patient management and therapeutic results. Advanced drug therapies are innovative treatments that utilize new technologies and research to more effectively manage complex health conditions. These therapies aim to boost effectiveness, decrease side effects, and provide better outcomes for patients. For example, in March 2022, Novartis AG, a Switzerland-based pharmaceutical company, announced the European Commission’s approval of Beovu for the treatment of visual impairment linked to diabetic macular edema (DME). This approval was granted based on the outcomes of the Phase III KESTREL and KITE studies, which demonstrated Beovu’s effectiveness in improving vision over one year was comparable to aflibercept. Notably, more than half of the patients treated with Beovu maintained a 12-week treatment schedule, exhibiting fewer instances of retinal fluid compared to aflibercept.
Which Key Players Are Driving Competition In The Diabetic Macular Edema (DME) Market?
Major companies operating in the diabetic macular edema (DME) market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Novartis AG, Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals, Carl Zeiss Meditec AG, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Carl Zeiss AG, Topcon Corporation, Ypsomed AG, ARKRAY Inc, Hugel Inc., Optos plc, Noven Pharmaceuticals Inc., Alimera Sciences Inc., Allergan plc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/diabetic-macular-edema-dme-global-market-report
Which Global Regions Are Influencing The Competitive Landscape Of The Diabetic Macular Edema (DME) Market?
North America was the largest region in the diabetic macular edema (DME) market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic macular edema (DME) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Diabetic Macular Edema (DME) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=21169&type=smp
Browse Through More Reports Similar to the Global Diabetic Macular Edema (DME) Market 2025, By The Business Research Company
Diabetes Care Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report
Artificial Intelligence In Diabetes Management Global Market Report 2025
Type 1 Diabetes Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/type-1-diabetes-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model